BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 35302652)

  • 1. Modern developments in germline pharmacogenomics for oncology prescribing.
    Reizine NM; O'Donnell PH
    CA Cancer J Clin; 2022 Jul; 72(4):315-332. PubMed ID: 35302652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinically actionable genotypes for anticancer prescribing among >1500 patients with pharmacogenomic testing.
    Reizine NM; Danahey K; Truong TM; George D; House LK; Karrison TG; van Wijk XMR; Yeo KJ; Ratain MJ; O'Donnell PH
    Cancer; 2022 Apr; 128(8):1649-1657. PubMed ID: 35090043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline pharmacogenomics in oncology: decoding the patient for targeting therapy.
    O'Donnell PH; Ratain MJ
    Mol Oncol; 2012 Apr; 6(2):251-9. PubMed ID: 22321460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analyzing the clinical actionability of germline pharmacogenomic findings in oncology.
    Wellmann R; Borden BA; Danahey K; Nanda R; Polite BN; Stadler WM; Ratain MJ; O'Donnell PH
    Cancer; 2018 Jul; 124(14):3052-3065. PubMed ID: 29742281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics in early-phase oncology clinical trials: is there a sweet spot in phase II?
    O'Donnell PH; Stadler WM
    Clin Cancer Res; 2012 May; 18(10):2809-16. PubMed ID: 22427349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Value of Pharmacogenetics to Reduce Drug-Related Toxicity in Cancer Patients.
    Mhandire DZ; Goey AKL
    Mol Diagn Ther; 2022 Mar; 26(2):137-151. PubMed ID: 35113367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetic testing in oncology: a Brazilian perspective.
    Suarez-Kurtz G
    Clinics (Sao Paulo); 2018 Oct; 73(suppl 1):e565s. PubMed ID: 30328952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics: Driving Personalized Medicine.
    Sadee W; Wang D; Hartmann K; Toland AE
    Pharmacol Rev; 2023 Jul; 75(4):789-814. PubMed ID: 36927888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatic pharmacogenomics in cancer.
    Ikediobi ON
    Pharmacogenomics J; 2008 Oct; 8(5):305-14. PubMed ID: 18679398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision Medicine in Oncology Pharmacy Practice.
    Saadeh C; Bright D; Rustem D
    Acta Med Acad; 2019 Apr; 48(1):90-104. PubMed ID: 31264437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of Germline Pharmacogenetics Into a Tumor Sequencing Program.
    Hertz DL; Glatz A; Pasternak AL; Lonigro RJ; Vats P; Wu YM; Anderson B; Rabban E; Mora E; Frank K; Robinson DR; Mody RJ; Chinnaiyan A
    JCO Precis Oncol; 2018; 2():. PubMed ID: 32832831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unraveling heterogeneity of the clinical pharmacogenomic guidelines in oncology practice among major regulatory bodies.
    Nagy M; Attya M; Patrinos GP
    Pharmacogenomics; 2020 Nov; 21(17):1247-1264. PubMed ID: 33124490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomic Germline Testing: Applications in Oncology Nursing.
    Germany J; Kueber J
    Clin J Oncol Nurs; 2023 Mar; 27(2):129-133. PubMed ID: 37677833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current state assessment survey of challenges of pharmacogenomics within oncology pharmacy practice.
    Przybylski DJ; Dow-Hillgartner EN; Reed MP; Fallon MJ
    J Oncol Pharm Pract; 2020 Sep; 26(6):1374-1381. PubMed ID: 31937189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline genetic variants with implications for disease risk and therapeutic outcomes.
    Pasternak AL; Ward KM; Luzum JA; Ellingrod VL; Hertz DL
    Physiol Genomics; 2017 Oct; 49(10):567-581. PubMed ID: 28887371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants found in paediatric oncology patients with severe chemotherapy-induced toxicity: A case series.
    Bernsen EC; Hanff LM; Haveman LM; Tops B; van der Lee M; Swen JJ; Huitema A; Diekstra M
    J Oncol Pharm Pract; 2023 Jul; 29(5):1237-1245. PubMed ID: 36464835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline oncopharmacogenetics, a promising field in cancer therapy.
    Pesenti C; Gusella M; Sirchia SM; Miozzo M
    Cell Oncol (Dordr); 2015 Feb; 38(1):65-89. PubMed ID: 25573079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating pharmacogenomic testing into paired germline and somatic genomic testing in patients with cancer.
    Seligson ND; Kolesar JM; Alam B; Baker L; Lamba JK; Fridley BL; Salahudeen AA; Hertz DL; Hicks JK
    Pharmacogenomics; 2023 Aug; 24(13):731-738. PubMed ID: 37702060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenomics-guided supportive oncology: A tale of two trials.
    Patel JN; Arnall J; Jandrisevits E; Morse AL; Steuerwald N; Copelan E; Walsh D
    Contemp Clin Trials; 2021 Jun; 105():106391. PubMed ID: 33819640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical pharmacy pilot within a Precision Medicine Program for cancer patients and review of related pharmacist clinical practice.
    Arnall JR; Petro R; Patel JN; Kennedy L
    J Oncol Pharm Pract; 2019 Jan; 25(1):179-186. PubMed ID: 29078708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.